These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2290972)

  • 1. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor.
    Carvey PM; McRae A; Ptak LR; Kao LC; Lo ES; Goetz CG; Tanner CM; Penn RD; Klawans HL
    Prog Brain Res; 1990; 82():693-7. PubMed ID: 2290972
    [No Abstract]   [Full Text] [Related]  

  • 2. Striatal adrenal medulla/sural nerve cografts in hemiparkinsonian monkeys.
    Hansen JT; Fiandaca MS; Kordower JH; Notter MF; Gash DM
    Prog Brain Res; 1990; 82():573-80. PubMed ID: 2290959
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of action of adrenal medulla grafts: the possible role of peripheral and central dopamine systems.
    Becker JB; Curran EJ; Freed WJ; Poltorak M
    Prog Brain Res; 1990; 82():499-507. PubMed ID: 2127117
    [No Abstract]   [Full Text] [Related]  

  • 4. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation.
    McRae-Degueurce A; Klawans HL; Penn RD; Dahlstrom A; Tanner CM; Goetz CG; Carvey PM
    Neurosci Lett; 1988 Nov; 94(1-2):192-7. PubMed ID: 3241668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease.
    Carvey PM; McRae A; Lint TF; Ptak LR; Lo ES; Goetz CG; Klawans HL
    Neurology; 1991 May; 41(5 Suppl 2):53-8; discussion 59-60. PubMed ID: 2041594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease.
    Freed WJ; Geller HM; Poltorak M; Cannon-Spoor HE; Cottingham SL; LaMarca ME; Schultzberg M; Rehavi M; Paul S; Ginns EI
    Prog Brain Res; 1990; 82():11-21. PubMed ID: 1981273
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible mechanisms of action of adrenal transplants in Parkinson's disease.
    Drucker-Colín R; García-Hernández F; Mendoza-Ramírez JL; Pacheco-Cano MT; Komisaruk BR
    Prog Brain Res; 1990; 82():509-14. PubMed ID: 1963226
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential regulation of striatal dopamine D1 and D2 receptor systems in Parkinson's disease and effects of adrenal medullary transplant.
    Joyce JN; Hurtig H
    Prog Brain Res; 1990; 82():699-706. PubMed ID: 2290973
    [No Abstract]   [Full Text] [Related]  

  • 9. Is autologous transplant of adrenal medulla into the striatum an effective therapy for Parkinson's disease?
    Garcia Flores E; Decanini HL; Flores Salazar M; Lozano Morales E; Zuniga MC; Martinez Campos A
    Prog Brain Res; 1990; 82():643-55. PubMed ID: 2290966
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous adrenal medulla to caudate nucleus transplantation in advanced Parkinson's disease: 18 month results.
    Cahill DW; Olanow CW
    Prog Brain Res; 1990; 82():637-42. PubMed ID: 2290965
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary report on adrenal medullary grafting and cografting with sural nerve in the treatment of hemiparkinson monkeys.
    Watts RL; Bakay RA; Herring CJ; Sweeney KM; Colbassani HJ; Mandir A; Byrd LD; Iuvone PM
    Prog Brain Res; 1990; 82():581-91. PubMed ID: 2290960
    [No Abstract]   [Full Text] [Related]  

  • 12. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum.
    Carvey PM; Ptak LR; Kao L; Klawans HL
    Clin Neuropharmacol; 1989 Oct; 12(5):425-34. PubMed ID: 2611766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal medulla graft induced recovery of function in an animal model of Parkinson's disease: possible mechanisms of action.
    Becker JB; Curran EJ; Freed WJ
    Can J Psychol; 1990 Jun; 44(2):293-310. PubMed ID: 2200596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of neurotrophic factors in therapy of Parkinson's disease.
    Möller JC; Sautter J; Kupsch A
    J Neural Transm Suppl; 1996; 48():103-12. PubMed ID: 8988466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal chromaffin cells as multipotential neurons for autografts.
    Mahanthappa NK; Gage FH; Patterson PH
    Prog Brain Res; 1990; 82():33-9. PubMed ID: 2290947
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of human neural transplantation.
    García Flores E
    Neurosurgery; 1992 Apr; 30(4):651-2. PubMed ID: 1584370
    [No Abstract]   [Full Text] [Related]  

  • 17. The adrenal medullary transplant operation: the Chicago experience. The Rush Research Group and Colleagues.
    Prog Brain Res; 1990; 82():627-35. PubMed ID: 2290964
    [No Abstract]   [Full Text] [Related]  

  • 18. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
    Hirsch EC; Duyckaerts C; Javoy-Agid F; Hauw JJ; Agid Y
    Ann Neurol; 1990 Jun; 27(6):676-82. PubMed ID: 2360804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracerebral transplantation of the adrenal medulla in rats with experimental Parkinson's disease.
    Dymecki J; Półtorak M; Markiewicz D; Hauptman M; Dziedziak W; Kostowski W
    Neuropatol Pol; 1986; 24(1):29-42. PubMed ID: 3748403
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms.
    Yong VW; Guttman M; Kim SU; Calne DB; Turnbull I; Watabe K; Tomlinson RW
    J Neurol Sci; 1989 Dec; 94(1-3):51-67. PubMed ID: 2614476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.